Literature DB >> 15868766

Managing cardiovascular risk in minority patients.

Keith C Ferdinand1.   

Abstract

In the United States, large and growing minority populations, including African Americans, Hispanic Americans and South Asians, are highly susceptible to the development of cardiovascular disease. Compared with Americans of other ancestries, these populations exhibit a higher prevalence of a number of risk factors, such as dyslipidemia, hypertension, obesity and diabetes mellitus. The clustering of risk factors in these groups is also greater than in white populations. Despite the considerable burden imposed by cardiovascular disease, African Americans, Hispanic Americans and South Asians remain inadequately targeted for risk-reduction strategies, including screening and treatment for dyslipidemia. In addition, these groups have traditionally been underrepresented in trials of lipid-modifying therapy. Large, ongoing epidemiologic and clinical trials will add to our knowledge of cardiovascular risk in these minority populations and contribute to recommendations to improve risk management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868766      PMCID: PMC2568747     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  45 in total

1.  Epidemic of cardiovascular disease in South Asians.

Authors:  Raj Bhopal
Journal:  BMJ       Date:  2002-03-16

2.  Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey.

Authors:  Karin Nelson; Keith Norris; Carol M Mangione
Journal:  Arch Intern Med       Date:  2002-04-22

3.  C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors.

Authors:  D G Cook; M A Mendall; P H Whincup; I M Carey; L Ballam; J E Morris; G J Miller; D P Strachan
Journal:  Atherosclerosis       Date:  2000-03       Impact factor: 5.162

4.  Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study.

Authors:  F L Brancati; W H Kao; A R Folsom; R L Watson; M Szklo
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

5.  Community-wide coronary heart disease mortality in Mexican Americans equals or exceeds that in non-Hispanic whites: the Corpus Christi Heart Project.

Authors:  D K Pandey; D R Labarthe; D C Goff; W Chan; M Z Nichaman
Journal:  Am J Med       Date:  2001-02-01       Impact factor: 4.965

6.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

7.  Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M A Winkleby; T N Robinson; J Sundquist; H C Kraemer
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

8.  Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects.

Authors:  Milan Gupta; Anand V Doobay; Narendra Singh; Sonia S Anand; Faisal Raja; Fazeelat Mawji; Julian Kho; Alice Karavetian; Qilong Yi; Salim Yusuf
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

9.  The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.

Authors:  C B Cook; D M Erdman; G J Ryan; K J Greenlund; W H Giles; D L Gallina; I M El-Kebbi; D C Ziemer; K L Ernst; V G Dunbar; L S Phillips
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

Review 10.  Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications.

Authors:  Anoop Misra; Naval K Vikram
Journal:  Nutrition       Date:  2004-05       Impact factor: 4.008

View more
  9 in total

1.  Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.

Authors:  David J Taber; Kelly J Hunt; Cory E Fominaya; Elizabeth H Payne; Mulugeta Gebregziabher; Titte R Srinivas; Prabhakar K Baliga; Leonard E Egede
Journal:  Hypertension       Date:  2016-07-11       Impact factor: 10.190

2.  Methods for estimation of disparities in medication use in an observational cohort study: results from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Robyn L McClelland; Neal W Jorgensen; Wendy S Post; Moyses Szklo; Richard A Kronmal
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-02-04       Impact factor: 2.890

3.  A coronary heart disease risk score based on patient-reported information.

Authors:  Arch G Mainous; Richelle J Koopman; Vanessa A Diaz; Charles J Everett; Peter W F Wilson; Barbara C Tilley
Journal:  Am J Cardiol       Date:  2007-03-13       Impact factor: 2.778

4.  Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes.

Authors:  Christine Hachem; Robert Morgan; Michael Johnson; Mark Kuebeler; Hashem El-Serag
Journal:  Am J Gastroenterol       Date:  2009-04-07       Impact factor: 10.864

5.  The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?

Authors:  Keith C Ferdinand
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-03       Impact factor: 3.738

6.  Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus.

Authors:  Alison L Harte; Nancy F da Silva; Michelle A Miller; Francesco P Cappuccio; Ann Kelly; Joseph P O'Hare; Anthony H Barnett; Nasser M Al-Daghri; Omar Al-Attas; Majed Alokail; Shaun Sabico; Gyanendra Tripathi; Srikanth Bellary; Sudhesh Kumar; Philip G McTernan
Journal:  Exp Diabetes Res       Date:  2012-03-01

7.  Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement.

Authors:  Erin D Michos; Tina K Reddy; Martha Gulati; LaPrincess C Brewer; Rachel M Bond; Gladys P Velarde; Alison L Bailey; Melvin R Echols; Samar A Nasser; Harold E Bays; Ann Marie Navar; Keith C Ferdinand
Journal:  Am J Prev Cardiol       Date:  2021-08-20

8.  Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia.

Authors:  Julia Chackathayil; Jeetesh V Patel; Paramjit S Gill; Rahul Potluri; Ammar Natalwala; Hardeep Uppal; Deepthi Lavu; Reinhard Heun; Elizabeth A Hughes; Gregory Y H Lip
Journal:  Int J Endocrinol       Date:  2013-02-19       Impact factor: 3.257

9.  Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies.

Authors:  Timothy R Smith; Thomas Philipp; Bernard Vaisse; George L Bakris; Margaret Wernsing; Joseph Yen; Robert Glazer
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-05       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.